Previa Medical, a deeptech startup specializing in the development of predictive medicine tools.
Previa has developed SEPSI-SCORE©, an artificial intelligence solution specialized in the early detection of sepsis, certified as a medical device in 2021. The platform alerts healthcare professionals up to 48 hours before the first symptoms. Integrated into the hospital’s business software, it analyzes patient medical records in real-time. It allows healthcare professionals to identify risks accurately, start the care protocol as quickly as possible, and thus increase patient survival.
M2care invests financially and humanly during the Pre-Seed round, aiming to achieve regulatory and clinical milestones, prepare the company’s commercial development, and develop new indications.
